These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 229802)

  • 21. Inhibition of herpes simplex virus replication by phosphonoacetic acid.
    Overby LR; Robishaw EE; Schleicher JB; Rueter A; Shipkowitz NL; Mao JC
    Antimicrob Agents Chemother; 1974 Sep; 6(3):360-5. PubMed ID: 15830487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differentiation of herpes simplex virus type 1 and type 2 by intranuclear tubular structures in clinical infection.
    Maekawa M; Hino Y; Mori R; Hayashi Y; Oda H
    Microbiol Immunol; 1981; 25(8):847-51. PubMed ID: 6270510
    [No Abstract]   [Full Text] [Related]  

  • 23. Herpes simplex type 1 defective interfering particles do not affect the antiviral activity of acyclovir, foscarnet and adenine arabinoside.
    Harmenberg JG; Svensson LT
    Acta Virol; 1988 Mar; 32(2):153-5. PubMed ID: 2899962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of acyclovir on the deoxyribonucleoside triphosphate pool levels in Vero cells infected with herpes simplex virus type 1.
    Furman PA; Lambe CU; Nelson DJ
    Am J Med; 1982 Jul; 73(1A):14-7. PubMed ID: 6285704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristics of herpes simplex virus resistance to disodium phosphonoacetate.
    Duff RG; Robishaw EE; Mao JC; Overby LR
    Intervirology; 1978; 9(4):193-205. PubMed ID: 201588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined interaction of antiherpes substances and interferon beta on the multiplication of herpes simplex virus.
    Janz C; Wigand R
    Arch Virol; 1982; 73(2):135-43. PubMed ID: 6184033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Timing of some of the molecular events required for cell fusion induced by herpes simplex virus type 1.
    Kousoulas KG; Person S; Holland TC
    J Virol; 1978 Sep; 27(3):505-12. PubMed ID: 212579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mode of action of phosphonoformate as an anti-herpes simplex virus agent.
    Cheng YC; Grill S; Derse D; Chen JY; Caradonna SJ; Connor K
    Biochim Biophys Acta; 1981 Jan; 652(1):90-8. PubMed ID: 6260189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deoxyribonucleic acid polymerase of wild-type and phosphonoacetic acid-resistant mutant of herpes simplex virus.
    Fridlender B; Chejanovsky N; Becker Y
    Antimicrob Agents Chemother; 1978 Jan; 13(1):124-7. PubMed ID: 204249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphonoacetic acid induced persistence of varicella-zoster virus in cell culture.
    Walz-Cicconi MA; Martindale KL; Weller TH
    Proc Soc Exp Biol Med; 1980 Jan; 163(1):30-5. PubMed ID: 6243413
    [No Abstract]   [Full Text] [Related]  

  • 31. In vitro synthesis of DNA in nuclei isolated from herpes simplex virus-infected cells, untreated and treated with metabolic inhibitors.
    Becker Y; Asher Y
    Virology; 1975 Jan; 63(1):209-20. PubMed ID: 163048
    [No Abstract]   [Full Text] [Related]  

  • 32. Isolation of herpes simplex virus clones and drug resistant mutants in microcultures.
    Klein RJ
    Arch Virol; 1975; 49(1):73-80. PubMed ID: 172951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of triterpenoid compounds on uninfected and herpes simplex virus-infected cells in culture. II. DNA and protein synthesis, polypeptide processing and transport.
    Dargan DJ; Subak-Sharpe JH
    J Gen Virol; 1986 Sep; 67 ( Pt 9)():1831-50. PubMed ID: 3018126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electron microscope observations on tubular structures in cells infected with herpes simplex virus type 2.
    Oda H; Mori R
    Arch Virol; 1976; 50(1-2):159-68. PubMed ID: 176968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lamellar structures found in cells infected with herpes simplex virus type 1.
    Oda H; Hirakawa K; Maekawa M; Hayashi Y; Mori R
    Microbiol Immunol; 1981; 25(9):959-63. PubMed ID: 6273703
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of 5-iodo-2'-deoxyuridine on ultrastructural localization of viral antigens in cultured cells infected with herpes simplex virus.
    Yoshida H; Sakata H; Hiyama N; Iwamoto T
    Jpn J Ophthalmol; 1983; 27(2):321-39. PubMed ID: 6312145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiplicity dependence and sensitivity of herpes simplex virus isolates to antiviral compounds.
    Harmenberg J; Wahren B; Sundqvist VA; Levén B
    J Antimicrob Chemother; 1985 May; 15(5):567-73. PubMed ID: 2989239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The synthesis of the major DNA-binding protein (ICP8) in cells infected with the strain HSZP or KOS of herpes simplex virus type 1.
    Matis J; Krivjanská M
    Acta Virol; 1991 Jan; 35(1):44-53. PubMed ID: 1683115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Replication of herpes simplex virus DNA after removal of hydroxyurea block from infected cells.
    Shlomai J; Becker Y
    J Gen Virol; 1977 Nov; 37(2):429-33. PubMed ID: 200715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of herpes simplex virus type 1 infection on the cellular DNA polymerase activities of mouse cell cultures.
    Radsak K
    J Gen Virol; 1978 Dec; 41(3):479-91. PubMed ID: 217947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.